Float Short %

13.27

Margin Of Safety %

Put/Call OI Ratio

1.1

EPS Next Q Diff

0.95

EPS Last/This Y

4.38

EPS This/Next Y

Price

Target Price

114.56

Analyst Recom

1.11

Performance Q

14.64

Relative Volume

0.97

Beta

-2.56

Ticker: SLNO

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-07-04	SLNO	86.65	1.02	0.13	45409
2025-07-07	SLNO	85.19	1.01	0.32	45647
2025-07-08	SLNO	85.26	1.01	0.82	45855
2025-07-09	SLNO	88.05	1.01	0.48	45943
2025-07-10	SLNO	80.76	0.99	0.54	47582
2025-07-11	SLNO	81.43	1.01	0.11	50171
2025-07-14	SLNO	82.76	0.99	0.26	51488
2025-07-15	SLNO	83.15	0.94	2.09	54010
2025-07-16	SLNO	85.52	0.94	1.01	54038
2025-07-17	SLNO	87.71	0.94	0.70	54101
2025-07-18	SLNO	87.19	0.94	5.12	54200
2025-07-21	SLNO	87.01	1.07	8.61	37229
2025-07-22	SLNO	86.05	1.09	0.53	37705
2025-07-23	SLNO	87.5	1.09	0.38	37729
2025-07-24	SLNO	88.03	1.09	0.15	37732
2025-07-25	SLNO	86.48	1.08	5.32	37619
2025-07-28	SLNO	85.3	1.10	1.54	37956
2025-07-29	SLNO	83.97	1.10	1.18	37982
2025-07-30	SLNO	84.86	1.10	0.26	37972
2025-07-31	SLNO	86.46	1.10	0.00	37994
2025-08-01	SLNO	86.04	1.10	2.60	37972
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-07-04	SLNO	86.65	-	-	0.00
2025-07-07	SLNO	85.25	-	-	0.00
2025-07-08	SLNO	85.26	-	-	0.00
2025-07-09	SLNO	88.49	-	-	0.00
2025-07-10	SLNO	80.32	-	-	0.00
2025-07-11	SLNO	81.57	-	-	0.00
2025-07-14	SLNO	82.76	-	-	0.00
2025-07-15	SLNO	83.59	-	-	0.00
2025-07-16	SLNO	85.57	-	-	0.00
2025-07-17	SLNO	87.64	-	-	0.00
2025-07-18	SLNO	87.19	-	-	0.00
2025-07-21	SLNO	87.00	-	-	0.00
2025-07-22	SLNO	86.05	-	-	0.00
2025-07-23	SLNO	87.45	-	-	0.00
2025-07-24	SLNO	88.03	-	-	0.00
2025-07-25	SLNO	86.47	-	-	0.00
2025-07-28	SLNO	85.62	-	-	0.00
2025-07-29	SLNO	83.97	-	-	0.00
2025-07-30	SLNO	84.86	-	-	0.00
2025-07-31	SLNO	86.47	-	-	0.00
2025-08-01	SLNO	86.00	-	-	0.00
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-07-04	SLNO	-25.70	9.50	9.73
2025-07-07	SLNO	-25.46	9.56	9.73
2025-07-08	SLNO	-25.46	9.56	9.73
2025-07-09	SLNO	-25.46	9.56	9.73
2025-07-10	SLNO	-25.46	9.56	9.73
2025-07-11	SLNO	-25.46	9.56	12.82
2025-07-14	SLNO	-25.46	9.41	12.82
2025-07-15	SLNO	-25.46	9.41	12.82
2025-07-16	SLNO	-24.61	9.41	12.25
2025-07-17	SLNO	-24.61	9.41	12.25
2025-07-18	SLNO	-24.61	9.41	12.25
2025-07-21	SLNO	-24.61	6.88	12.25
2025-07-22	SLNO	-24.61	6.88	12.25
2025-07-23	SLNO	-24.61	6.88	12.25
2025-07-24	SLNO	-24.61	6.88	12.25
2025-07-25	SLNO	-24.61	6.88	13.42
2025-07-28	SLNO	-24.61	9.39	13.27
2025-07-29	SLNO	-25.69	9.39	13.27
2025-07-30	SLNO	-25.69	9.39	13.27
2025-07-31	SLNO	-25.69	9.39	13.27
2025-08-01	SLNO	-25.69	9.39	13.27
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.95

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

-25.69

Institutional Transactions

9.39

Beta

-2.56

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

4.8

Max Drawdown 5-Year %

-98.2

Target Price

114.56

P/E

Forward P/E

52.76

PEG

P/S

P/B

17.97

P/Free Cash Flow

EPS

-4.62

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.97

Return on Equity vs Sector %

-109.1

Return on Equity vs Industry %

-90.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Soleno Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 115

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

stock quote shares SLNO – Soleno Therapeutics Inc Stock Price stock today

news today SLNO – Soleno Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SLNO – Soleno Therapeutics Inc yahoo finance google finance

stock history SLNO – Soleno Therapeutics Inc invest stock market

stock prices SLNO premarket after hours

ticker SLNO fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: SLNO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y